Paper33430823
Toward patient-centered tuberculosis preventive treatment: preferences for regimens and formulations in Lima, Peru.
Yuen CM and 7 others. BMC Public Health, 2021. Cited by 27 papers, by iCite.
Cite this record
ConductScience Library. Toward patient-centered tuberculosis preventive treatment: preferences for regimens and formulations in Lima, Peru. Papers, record 33430823. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33430823
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Isoniazid | Major topic |
| Tuberculosis | Major topic |
| Antitubercular Agents | |
| Child | |
| Clinical Protocols | |
| Drug Therapy, Combination | |
| Humans | |
| Patient-Centered Care | |
| Peru |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| DP2 MD015102 | NIMHD NIH HHS | United States | DP2MD015102 | PubMed and NIH |
Source NIH RePORTER
References23
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31100097 | Tuberculosis household accompaniment to improve the contact management cascade: A prospective cohort study. | PLoS One | 2019 | https://conductscience.org/library/papers/31100097 | PubMed |
| 2 | 28763500 | Child contact management in high tuberculosis burden countries: A mixed-methods systematic review. | PLoS One | 2017 | https://conductscience.org/library/papers/28763500 | PubMed |
| 3 | 31908872 | One size does not fit all: preventing tuberculosis among child contacts. | BMJ Glob Health | 2019 | https://conductscience.org/library/papers/31908872 | PubMed |
| 4 | 31980498 | Treatment with isoniazid or rifampin for latent tuberculosis infection: population-based study of hepatotoxicity, completion and costs. | Eur Respir J | 2020 | https://conductscience.org/library/papers/31980498 | PubMed |
| 5 | 21319484 | Qualitative data analysis: the framework approach. | Nurse Res | 2011 | https://conductscience.org/library/papers/21319484 | PubMed |
| 6 | 15636498 | The influence of risk factors on the severity of anti-tuberculosis drug-induced hepatotoxicity. | Int J Tuberc Lung Dis | 2004 | https://conductscience.org/library/papers/15636498 | PubMed |
| 7 | 29506608 | Long-acting formulations for the treatment of latent tuberculous infection: opportunities and challenges. | Int J Tuberc Lung Dis | 2018 | https://conductscience.org/library/papers/29506608 | PubMed |
| 8 | 29363561 | Completion Rate and Safety of Tuberculosis Infection Treatment With Shorter Regimens. | Pediatrics | 2018 | https://conductscience.org/library/papers/29363561 | PubMed |
| 9 | 30881174 | Health literacy and knowledge related to tuberculosis among outpatients at a referral hospital in Lima, Peru. | Res Rep Trop Med | 2019 | https://conductscience.org/library/papers/30881174 | PubMed |
| 10 | 29991393 | Tuberculosis preventive treatment preferences among care givers of children in Lesotho: a pilot study. | Int J Tuberc Lung Dis | 2018 | https://conductscience.org/library/papers/29991393 | PubMed |
| 11 | 27863675 | Age-appropriate and acceptable paediatric dosage forms: Insights into end-user perceptions, preferences and practices from the Children's Acceptability of Oral Formulations (CALF) Study. | Int J Pharm | 2016 | https://conductscience.org/library/papers/27863675 | PubMed |
| 12 | 27522233 | The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis. | Lancet Infect Dis | 2016 | https://conductscience.org/library/papers/27522233 | PubMed |
| 13 | 26515679 | Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection. | Lancet | 2015 | https://conductscience.org/library/papers/26515679 | PubMed |
| 14 | 21914516 | Patient preference for latent tuberculosis infection preventive treatment: a discrete choice experiment. | Value Health | 2011 | https://conductscience.org/library/papers/21914516 | PubMed |
| 15 | 28234078 | Barriers to the treatment of childhood tuberculous infection and tuberculosis disease: a qualitative study. | Int J Tuberc Lung Dis | 2017 | https://conductscience.org/library/papers/28234078 | PubMed |
| 16 | 32448887 | Concordance of Drug-resistance Profiles Between Persons With Drug-resistant Tuberculosis and Their Household Contacts: A Systematic Review and Meta-analysis. | Clin Infect Dis | 2021 | https://conductscience.org/library/papers/32448887 | PubMed |
| 17 | 29130574 | Drug interactions between rifamycin antibiotics and hormonal contraception: a systematic review. | BJOG | 2018 | https://conductscience.org/library/papers/29130574 | PubMed |
| 18 | 30335466 | Moving toward Tuberculosis Elimination. Critical Issues for Research in Diagnostics and Therapeutics for Tuberculosis Infection. | Am J Respir Crit Care Med | 2019 | https://conductscience.org/library/papers/30335466 | PubMed |
| 19 | 31758837 | Contact evaluation and isoniazid preventive therapy among close and household contacts of tuberculosis patients in Lima, Peru: an analysis of routine data. | Trop Med Int Health | 2020 | https://conductscience.org/library/papers/31758837 | PubMed |
| 20 | 29297450 | Knowledge of tuberculosis and vaccine trial preparedness in Lima, Peru. | Int J Tuberc Lung Dis | 2017 | https://conductscience.org/library/papers/29297450 | PubMed |
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42758766 | Scaling-up tuberculosis preventive therapy to HIV-negative contacts of bacteriologically confirmed TB cases aged 5 years and above - Lessons from a tuberculosis preventive therapy surge activity in Zambia. | PLOS Glob Public Health | 2026 | https://conductscience.org/library/papers/42758766 | PubMed |
| 42369968 | Infectious Disease Provider Perspectives on Shorter Tuberculosis Treatment Regimens. | Open Forum Infect Dis | 2026 | https://conductscience.org/library/papers/42369968 | PubMed |
| 41918956 | Challenges and Opportunities for Improved Tuberculosis and HIV Prevention in South America. | Open Forum Infect Dis | 2026 | https://conductscience.org/library/papers/41918956 | PubMed |
| 41645075 | The effectiveness of preventive tuberculosis treatment in children. | BMC Infect Dis | 2026 | https://conductscience.org/library/papers/41645075 | PubMed |
| 41544145 | Identifying missed opportunities in tuberculosis preventive treatment care cascade: Analysis of programme data from Maharashtra, India. | PLOS Glob Public Health | 2026 | https://conductscience.org/library/papers/41544145 | PubMed |
| 41438863 | Acceptability of multidrug-resistant tuberculosis preventive treatment: a retrospective survey. | ERJ Open Res | 2025 | https://conductscience.org/library/papers/41438863 | PubMed |
| 41246465 | Optimising child-friendly TB preventive treatment regimens. | IJTLD Open | 2025 | https://conductscience.org/library/papers/41246465 | PubMed |
| 40623880 | Exploring tuberculosis patients' preferences for AI-assisted remote health management services in China: a protocol for a discrete choice experiment. | BMJ Open | 2025 | https://conductscience.org/library/papers/40623880 | PubMed |
| 40365033 | Patient and provider preferences for long-acting TB preventive therapy. | IJTLD Open | 2025 | https://conductscience.org/library/papers/40365033 | PubMed |
| 40264790 | Transforming Nursing Practice to Optimize Care of Patients with Tuberculosis and Associated Comorbidities in the Kilimanjaro Region, Tanzania. | Open Nurs J | 2025 | https://conductscience.org/library/papers/40264790 | PubMed |
| 39802236 | Children and providers' perspectives on once-weekly rifapentine and isoniazid TB preventive therapy. | IJTLD Open | 2025 | https://conductscience.org/library/papers/39802236 | PubMed |
| 39587885 | Preferences of people living with HIV for features of tuberculosis preventive treatment regimens in Uganda: a discrete choice experiment. | J Int AIDS Soc | 2024 | https://conductscience.org/library/papers/39587885 | PubMed |
| 39446746 | Evaluating the implementation of weekly rifapentine-isoniazid (3HP) for tuberculosis prevention among people living with HIV in Uganda: A qualitative evaluation of the 3HP Options Trial. | PLOS Glob Public Health | 2024 | https://conductscience.org/library/papers/39446746 | PubMed |
| 39028696 | Treatment preferences among people at risk of developing tuberculosis: A discrete choice experiment. | PLOS Glob Public Health | 2024 | https://conductscience.org/library/papers/39028696 | PubMed |
| 38966690 | Preference for daily (1HP) vs. weekly (3HP) isoniazid-rifapentine among people living with HIV in Uganda. | IJTLD Open | 2024 | https://conductscience.org/library/papers/38966690 | PubMed |
| 37353873 | TB preventive therapy preferences among children and adolescents. | Int J Tuberc Lung Dis | 2023 | https://conductscience.org/library/papers/37353873 | PubMed |
| 37292150 | A randomized controlled trial to evaluate the impact of pharmacist-led clinical interventions on the health-related quality of life among TB patients. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/37292150 | PubMed |
| 35581650 | Prioritising attributes for tuberculosis preventive treatment regimens: a modelling analysis. | BMC Med | 2022 | https://conductscience.org/library/papers/35581650 | PubMed |
| 34914696 | Completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV: Interim analysis of a hybrid type 3 effectiveness-implementation randomized trial. | PLoS Med | 2021 | https://conductscience.org/library/papers/34914696 | PubMed |
| 34686549 | Paediatric tuberculosis preventive treatment preferences among HIV-positive children, caregivers and healthcare providers in Eswatini: a discrete choice experiment. | BMJ Open | 2021 | https://conductscience.org/library/papers/34686549 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33430823
GET https://conductscience.org/api/papers/v1/33430823/references?page=2